E-Medicals UK Ltd - Period Ending 2023-03-31

E-Medicals UK Ltd - Period Ending 2023-03-31


E-Medicals UK Ltd 05247314 false 2022-04-01 2023-03-31 2023-03-31 The principal activity of the company is that of the provision of medico-legal services to the insurance industry. Digita Accounts Production Advanced 6.30.9574.0 true true 05247314 2022-04-01 2023-03-31 05247314 2023-03-31 05247314 bus:OrdinaryShareClass1 2023-03-31 05247314 bus:OrdinaryShareClass2 2023-03-31 05247314 bus:OrdinaryShareClass3 2023-03-31 05247314 bus:OrdinaryShareClass4 2023-03-31 05247314 bus:OrdinaryShareClass5 2023-03-31 05247314 bus:OtherShareClass1 2023-03-31 05247314 core:HirePurchaseContracts core:CurrentFinancialInstruments 2023-03-31 05247314 core:HirePurchaseContracts core:Non-currentFinancialInstruments 2023-03-31 05247314 core:CurrentFinancialInstruments 2023-03-31 05247314 core:CurrentFinancialInstruments core:WithinOneYear 2023-03-31 05247314 core:Non-currentFinancialInstruments 2023-03-31 05247314 core:Non-currentFinancialInstruments core:AfterOneYear 2023-03-31 05247314 core:FurnitureFittingsToolsEquipment 2023-03-31 05247314 core:LandBuildings 2023-03-31 05247314 core:MotorVehicles 2023-03-31 05247314 bus:SmallEntities 2022-04-01 2023-03-31 05247314 bus:AuditExemptWithAccountantsReport 2022-04-01 2023-03-31 05247314 bus:FullAccounts 2022-04-01 2023-03-31 05247314 bus:SmallCompaniesRegimeForAccounts 2022-04-01 2023-03-31 05247314 bus:RegisteredOffice 2022-04-01 2023-03-31 05247314 bus:CompanySecretaryDirector1 2022-04-01 2023-03-31 05247314 bus:Director5 2022-04-01 2023-03-31 05247314 bus:OrdinaryShareClass1 2022-04-01 2023-03-31 05247314 bus:OrdinaryShareClass2 2022-04-01 2023-03-31 05247314 bus:OrdinaryShareClass3 2022-04-01 2023-03-31 05247314 bus:OrdinaryShareClass4 2022-04-01 2023-03-31 05247314 bus:OrdinaryShareClass5 2022-04-01 2023-03-31 05247314 bus:OtherShareClass1 2022-04-01 2023-03-31 05247314 bus:PrivateLimitedCompanyLtd 2022-04-01 2023-03-31 05247314 core:FurnitureFittings 2022-04-01 2023-03-31 05247314 core:FurnitureFittingsToolsEquipment 2022-04-01 2023-03-31 05247314 core:LandBuildings 2022-04-01 2023-03-31 05247314 core:LeaseholdImprovements 2022-04-01 2023-03-31 05247314 core:MotorVehicles 2022-04-01 2023-03-31 05247314 core:OfficeEquipment 2022-04-01 2023-03-31 05247314 core:OtherRelatedParties 2022-04-01 2023-03-31 05247314 countries:EnglandWales 2022-04-01 2023-03-31 05247314 2022-03-31 05247314 core:FurnitureFittingsToolsEquipment 2022-03-31 05247314 core:LandBuildings 2022-03-31 05247314 core:MotorVehicles 2022-03-31 05247314 2021-04-01 2022-03-31 05247314 2022-03-31 05247314 bus:OrdinaryShareClass1 2022-03-31 05247314 bus:OrdinaryShareClass2 2022-03-31 05247314 bus:OrdinaryShareClass3 2022-03-31 05247314 bus:OrdinaryShareClass4 2022-03-31 05247314 bus:OrdinaryShareClass5 2022-03-31 05247314 bus:OtherShareClass1 2022-03-31 05247314 core:HirePurchaseContracts core:CurrentFinancialInstruments 2022-03-31 05247314 core:HirePurchaseContracts core:Non-currentFinancialInstruments 2022-03-31 05247314 core:CurrentFinancialInstruments 2022-03-31 05247314 core:CurrentFinancialInstruments core:WithinOneYear 2022-03-31 05247314 core:Non-currentFinancialInstruments 2022-03-31 05247314 core:Non-currentFinancialInstruments core:AfterOneYear 2022-03-31 05247314 core:FurnitureFittingsToolsEquipment 2022-03-31 05247314 core:LandBuildings 2022-03-31 05247314 core:MotorVehicles 2022-03-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 05247314

E-Medicals UK Ltd

Unaudited Filleted Financial Statements

for the Year Ended 31 March 2023

 

E-Medicals UK Ltd

Contents

Company Information

1

Balance Sheet

2

Notes to the Unaudited Financial Statements

3 to 8

 

E-Medicals UK Ltd

Company Information

Directors

E M Williams

S Munro

Company secretary

E M Williams

Registered office

Unit 2
Yeo Bank Business Park
Kenn Road
KENN
Clevedon
BS21 6UW

Accountants

Newsham Hanson Accountants Limited
Accountants and Business Advisors
Edinburgh House
1-5 Bellevue Road
Clevedon
North Somerset
BS21 7NP

 

E-Medicals UK Ltd

(Registration number: 05247314)
Balance Sheet as at 31 March 2023

Note

2023
£

2022
£

Fixed assets

 

Tangible assets

4

132,357

175,912

Current assets

 

Debtors

5

4,990,657

4,110,137

Cash at bank and in hand

 

611

611

 

4,991,268

4,110,748

Creditors: Amounts falling due within one year

6

(4,959,219)

(4,184,967)

Net current assets/(liabilities)

 

32,049

(74,219)

Total assets less current liabilities

 

164,406

101,693

Creditors: Amounts falling due after more than one year

6

(68,241)

(86,193)

Net assets

 

96,165

15,500

Capital and reserves

 

Called up share capital

7

10,005

10,005

Retained earnings

86,160

5,495

Shareholders' funds

 

96,165

15,500

For the financial year ending 31 March 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 13 December 2023 and signed on its behalf by:
 

.........................................
S Munro
Director

 

E-Medicals UK Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2023

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Unit 2
Yeo Bank Business Park
Kenn Road
KENN
Clevedon
BS21 6UW

These financial statements were authorised for issue by the Board on 13 December 2023.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

 

E-Medicals UK Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2023

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Leasehold property improvements

10% straight line basis

Fixtures & fittings

25% reducing balance basis

Motor vehicles

25% reducing balance basis

Office equipment

25% reducing balance basis

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

 

E-Medicals UK Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2023

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Leases

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessee.

Assets held under finance leases are recognised at the lower of their fair value at inception of the lease and the present value of the minimum lease payments. These assets are depreciated on a straight-line basis over the shorter of the useful life of the asset and the lease term. The corresponding liability to the lessor is included in the balance sheet as a finance lease obligation.

Lease payments are apportioned between finance costs in the profit and loss account and reduction of the lease obligation so as to achieve a constant periodic rate of interest on the remaining balance of the liability.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 11 (2022 - 15).

 

E-Medicals UK Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2023

4

Tangible assets

Land and buildings
£

Furniture, fittings and equipment
 £

Motor vehicles
 £

Total
£

Cost or valuation

At 1 April 2022

207,988

441,284

104,137

753,409

Additions

8,480

8,329

-

16,809

At 31 March 2023

216,468

449,613

104,137

770,218

Depreciation

At 1 April 2022

176,993

354,295

46,209

577,497

Charge for the year

21,617

24,265

14,482

60,364

At 31 March 2023

198,610

378,560

60,691

637,861

Carrying amount

At 31 March 2023

17,858

71,053

43,446

132,357

At 31 March 2022

30,995

86,989

57,928

175,912

Included within the net book value of tangible assets is £76,436 (2022 - £100,472) in respect of assets held under finance leases and similar hire purchase contracts. Depreciation for the year on these assets was £24,036 (2022 - £31,327).

Included within the net book value of land and buildings above is £17,858 (2022 - £30,996) in respect of long leasehold land and buildings.
 

5

Debtors

Current

2023
£

2022
£

Trade debtors

3,667,611

3,051,515

Prepayments

15,747

17,636

Other debtors

1,307,299

1,040,986

 

4,990,657

4,110,137

 

E-Medicals UK Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2023

6

Creditors

Creditors: amounts falling due within one year

Note

2023
£

2022
£

Due within one year

 

Bank loans and overdrafts

8

2,097,766

2,033,041

Trade creditors

 

1,958,072

1,456,573

Amounts owed to related parties

9

-

120

Taxation and social security

 

482,341

429,787

Other creditors

 

421,040

265,446

 

4,959,219

4,184,967

Due after one year

 

Loans and borrowings

8

68,241

86,193

Creditors: amounts falling due after more than one year

Note

2023
£

2022
£

Due after one year

 

Loans and borrowings

8

68,241

86,193

7

Share capital

Allotted, called up and fully paid shares

 

2023

2022

 

No.

£

No.

£

Ordinary shares of £1 each

10,000

10,000

10,000

10,000

Ordinary B shares of £1 each

1

1

1

1

Ordinary C shares of £1 each

1

1

1

1

Ordinary D shares of £1 each

1

1

1

1

Ordinary E shares of £1 each

1

1

1

1

Ordinary F shares of £1 each

1

1

1

1

 

10,005

10,005

10,005

10,005

 

E-Medicals UK Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2023

8

Loans and borrowings

2023
£

2022
£

Non-current loans and borrowings

Bank borrowings

35,185

40,741

Hire purchase contracts

33,056

45,452

68,241

86,193

2023
£

2022
£

Current loans and borrowings

Bank borrowings

5,556

5,555

Bank overdrafts

14,462

145,214

Hire purchase contracts

12,396

31,654

Other borrowings

2,065,352

1,850,618

2,097,766

2,033,041

9

Related party transactions

Summary of transactions with other related parties


S Munro and E Williams

 Directors and shareholders of the company.
 
During the year the company advanced the Directors £19,913 (S Munro - £9,967 and E Williams - £9,946). The closing balance of the advance to the Directors at the balance sheet date was £19,913. This advance remained outstanding at the year-end but was repaid in full by 31 December 2023. The company has charged interest of 2% on the average balance of the advance for the period of the loan. No special terms applied and the loan was repayable on demand.


 

10

Control

The company is controlled by the directors who own 99.98% of the called up share capital.